Brief: Hyphens Pharma International Proposes Acquisition Of 58% Of Share Capital In Ardence Pharma

Hyphens Pharma International

17/10/2023 11:29

Oct 17 (Reuters) - Hyphens Pharma International Ltd
 HYPH.SI :
    * PROPOSED ACQUISITION OF 58% OF SHARE CAPITAL IN ARDENCE
PHARMA
SDN BHD
    * ENTERED INTO TWO SALE AND PURCHASE AGREEMENTS WITH IREG
SOLUTION
SDN BHD AND MR LEE PAK HSIUNG
    * CONSIDERATION IS S$1.86 MILLION FOR TRANCHE 1 OF PROPOSED
ACQUISITION

Source text for Eikon:  ID:nSN6PPYQJ 
Further company coverage:  HYPH.SI 

 ((Reuters.Briefs@thomsonreuters.com;))